Ovarian Cancer News

• Mastectomy May Not Be Necessary for Young Breast Cancer Patients Mastectomies among younger women with nonmetastatic invasive breast cancer may not always be necessary, suggests a study that shows survival outcomes are similar after a lumpectomy.
  Medscape Medical News, May 17, 2022
• AACR 2022 Novel CAR T Therapy for Solid Tumors: 'Exciting Advance' The approach, which combines a chimeric antigen receptor with an RNA vaccine, showed early efficacy against advanced testicular and ovarian cancers.
  Medscape Medical News, April 18, 2022
• New Documentary Probes 'the Pill' Use is widespread: 12 million women are currently on the pill, and 80% of women have used it at some point in their life.
  WebMD Health News, April 11, 2022
• AAN 2022 Antiseizure Medication Appears Safe in Pregnancy Use of antiseizure medications while pregnant or breastfeeding is not associated with cognitive harm in children, results from two new studies show.
  Medscape Medical News, April 06, 2022
• Immune System-Generated Antibodies Combat Ovarian Tumors in a Lab Study The immune systems of ovarian cancer patients can produce antibodies against tumors, a cell-based study shows, and researchers suggest the finding could lead to a new type of immunotherapy.
  Reuters Health Information, April 04, 2022
• Rucaparib Bests Chemo in Relapsed Ovarian Cancer Results of the ARIEL4 study support the use of the PARP inhibitor rucaparib as an alternative to chemotherapy for patients with relapsed, BRCA1- or BRCA2-mutated ovarian cancer.
  Reuters Health Information, March 28, 2022
• Positive Phase 3 Data for PARP Inhibitor Niraparib in Ovarian Cancer Maintenance therapy with the PARP inhibitor niraparib improved progression-free survival, regardless of biomarker status, in women with newly diagnosed advanced epithelial ovarian, fallopian tube or primary peritoneal cancer enrolled in the PRIME trial.
  Reuters Health Information, March 25, 2022
• New Ultrasound Approach Simplifies Ovarian Cancer Detection in Average-Risk Women Radiologists have developed a simplified ultrasound approach for assessing adnexal masses in women at average risk for ovarian cancer.
  Reuters Health Information, March 24, 2022
• Complex Surgery 10 Times More Likely With Some Ovarian Tumors Complex surgery is much more likely for advanced ovarian cancer in women with mesenchymal tumors and complex preoperative CT findings.
  Medscape Medical News, March 24, 2022
• Can Nitrogen-Based Bisphosphonates Protect Against Ovarian Cancer? Use of nitrogen-based bisphosphonates was associated with a lower risk of endometrioid and serous ovarian cancer in a nested case-control study conducted in Australia.
  Reuters Health Information, March 18, 2022
• Olaparib in gBRCA+ Breast Cancer; 'Clearly Practice Changing' Longer-term results from the OlympiA trial show a 32% improvement in overall survival with olaparib among women with early-stage germline BRCA-mutated breast cancer.
  Medscape Medical News, March 18, 2022
• Injecting Asbestos: Prison Studies Revealed in J&J Talc Lawsuits Revealed during the J&J talc/cancer lawsuits is a study conducted 50 years ago in which prisoners were injected with asbestos. The study was conducted by a prominent dermatologist at the University of Pennsylvannia.
  Medscape Medical News, March 15, 2022
• Data Review: Spironolactone Not Linked to Increased Cancer Risk The drug's antiandrogenic properties have driven its off-label use as a treatment for acne, hidradenitis, androgenetic alopecia, and hirsutism, and it is also used in gender-affirming care.
  Medscape Medical News, February 22, 2022
• GUCS 2022 Twitter Storm Over 'Reprehensible Behavior' at Conference Podium A Twitter post calling out an exchange between a presenter and an attendee asking questions at the recent GUCS conference created a bit of a buzz.
  Medscape Medical News, February 22, 2022
• GUCS 2022 PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer Two new trials exploring this approach ― olaparib in the PROpel trial and niraparib in the MAGNITUDE trial –― had slightly different results.
  Medscape Medical News, February 22, 2022
• Removing Fallopian Tubes During Hysterectomy May Curb Ovarian Cancer Risk Removal of the fallopian tubes during hysterectomy or instead of tubal ligation was associated with fewer serous and epithelial ovarian cancers than expected in a retrospective analysis.
  Reuters Health Information, February 17, 2022
• Virtual Exams for Routine Surveillance After Ovarian Cancer Virtual visits may be a suitable alternative to the frequent in-person visits currently mandated for patients who are in remission from ovarian cancer.
  Medscape Medical News, February 15, 2022
• Older Age for Menopause Raises Risk for Lung Cancer An analysis of more than 116,000 menopausal women showed those with a later age of natural menopause had a 35% increased rate of lung cancer but decreased risk for osteoporosis and fracture.
  First Look, February 14, 2022
• Online Tool Helps Ovarian Cancer Patients Manage Symptoms An online symptom-management tool helps women with ovarian cancer get control over their symptoms.
  Reuters Health Information, February 11, 2022
• Changing Landscape of Uterine and Ovarian Cancer in the US The landscape of gynecologic cancer in the United States is changing rapidly and the risk of dying from uterine cancer is now similar to that for ovarian cancer among women overall, and roughly 60% higher among Black women, researchers say.
  Reuters Health Information, February 10, 2022